The aesthetic medicine industry is entering a new era — moving beyond traditional volume enhancement toward regenerative solutions that stimulate natural beauty from within.
As one of the most promising biostimulatory technologies, PLLA (Poly-L-Lactic Acid) has gained increasing attention among aesthetic professionals and patients worldwide for its ability to support collagen regeneration and deliver natural, progressive results.
At Dubai Derma 2026, Xihong Biopharma will showcase its advanced regenerative injectable portfolio and connect with global partners who share our vision for the future of aesthetic medicine.
With a strong focus on regenerative biomaterials and injectable aesthetic solutions, Xihong Biopharma is committed to developing high-quality products that empower global aesthetic brands and distributors.
Our portfolio includes innovative solutions across:
PLLA Biostimulators | CaHA Injectable Solutions | PDRN Regeneration Solutions | NCTF Skin Revitalization
With our PLLA product already receiving NMPA Class III Medical Device approval in China, Xihong Biopharma has established a strong foundation for international growth.
Building on this milestone, we are actively advancing regulatory pathways in key global markets, including:
✓ European Union — CE MDR Certification Pathway
✓ Saudi Arabia — SFDA Regulatory Pathway
✓ Brazil — ANVISA Registration Pathway
✓ Southeast Asia — Regional Market Access Strategy
Our vision is to bring safe, innovative, and effective regenerative aesthetic solutions to healthcare professionals and patients worldwide.
The global demand for collagen-stimulating treatments continues to grow as more patients seek natural-looking, long-lasting aesthetic outcomes.
With strong market performance in China and extensive clinical application experience, Xihong Biopharma’s PLLA solutions deliver natural and progressive collagen regeneration outcomes.Xihong Biopharma’s PLLA solutions are designed to support this market evolution with:
As we continue advancing our international regulatory pathway, our PLLA products are moving closer to global market opportunities.
With our upcoming global expansion plans, Xihong Biopharma is actively seeking qualified distributors and strategic partners for PLLA solutions.
We welcome partners who are looking to:
✓ Expand their regenerative aesthetic portfolio
✓ Introduce innovative collagen stimulation solutions into their markets
✓ Build long-term cooperation with a professional injectable manufacturer
Together, we aim to bring next-generation regenerative aesthetic solutions to more professionals and patients worldwide.
Dubai Derma 2026 will be an important milestone for Xihong Biopharma as we connect with global aesthetic leaders, distributors, and industry partners.
Visit us to explore our regenerative injectable portfolio and discuss future collaboration opportunities.
Xihong Biopharma
Your Trusted, One-Stop Injectable Solutions Partner
Booth：Zabeel Hall 1 1B04
Times：0908-10, 2026
Location：Dubai World Trade Center
Xihong Biopharma provides innovative regenerative injectable solutions for the global aesthetic industry, offering advanced PLLA technology, OEM manufacturing, and private label services.
Ready to grow your aesthetic business? Contact our team today to discuss PLLA products, OEM solutions, or partnership opportunities.
💬 +86 13310882353 | 📧 coop@dfyanmei.com | 🌐 www.xihongbiopharma.com
